Nosocomial diarrhea: Evaluation and treatment of causes other than clostridium difficile

Clinical Infectious Diseases

Volumn 55, Issue 7, 2012, Pages 982-989

  Polage, Christopher R ^a,b   Solnick, Jay V ^b,c   Cohen, Stuart H ^b  

^a Department of Pathology and Laboratory Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIDIARRHEAL AGENT; AURANOFIN; AZATHIOPRINE; CARVEDILOL; CLINDAMYCIN; COLCHICINE; DIDANOSINE; DIGOXIN; DONEPEZIL; FLUOROURACIL; INFUSION FLUID; IRINOTECAN; METFORMIN; METOCLOPRAMIDE; METRONIDAZOLE; MISOPROSTOL; MYCOPHENOLIC ACID; NELFINAVIR; OCTREOTIDE; OLSALAZINE; PYRIDOSTIGMINE; QUINIDINE; SERTRALINE; TACROLIMUS; TICLOPIDINE;

ANTIBIOTIC THERAPY; BACTEROIDES FRAGILIS; BLOODY DIARRHEA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG INDUCED DIARRHEA; DRUG INDUCED DISEASE; ENTERIC FEEDING; ENVIRONMENTAL EXPOSURE; FOOD POISONING; GASTROENTERITIS; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INFECTIOUS DIARRHEA; INTESTINE FLORA; KLEBSIELLA OXYTOCA; NOROVIRUS; NOSOCOMIAL DIARRHEA; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; CROSS INFECTION; DIARRHEA; DRUG TOXICITY; HUMANS; VIRUS DISEASES;

EID: 84866073288     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis551     Document Type: Review

References (51)

1. Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008; 51:478-86. (Pubitemid 351273473)
2. Lima NL, Guerrant RL, Kaiser DL, Germanson T, Farr BM. A retrospective cohort study of nosocomial diarrhea as a risk factor for noso-comial infection. J Infect Dis 1990; 161:948-52. (Pubitemid 20148329)
3. Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: patho-physiology, frequency and guideline-based management. Ther Adv Med Oncol 2010; 2:51-63.
4. Roddie C, Paul JP, Benjamin R, et al. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis 2009; 49:1061-8.
5. Kelly TW, Patrick MR, Hillman KM. Study of diarrhea in critically ill patients. Crit Care Med 1983; 11:7-9. (Pubitemid 13032283)
6. Wiesen P, Van Gossum A, Preiser JC. Diarrhoea in the critically ill. Curr Opin Crit Care 2006; 12:149-54.
7. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995; 23:295-305.
8. Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant 2006; 6:1466-72. (Pubitemid 44030331)
9. Ringel AF, Jameson GL, Foster ES. Diarrhea in the intensive care patient. Crit Care Clin 1995; 11:465-77.
10. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005; 11:881-90. (Pubitemid 41122444)
11. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107:1398-407. (Pubitemid 24328277)
12. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994; 18:181-7. (Pubitemid 24055256)
13. Garey KW, Graham G, Gerard L, et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother 2006; 40:1030-4. (Pubitemid 43886958)
14. Aksoy DY, Tanriover MD, Uzun O, et al. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic en-terocolitis. Ann Oncol 2007; 18:183-9. (Pubitemid 46152520)
15. Husain A, Aptaker L, Spriggs DR, Barakat RR. Gastrointestinal toxici-ty and Clostridium difficile diarrhea in patients treated with paclitaxel- containing chemotherapy regimens. Gynecol Oncol 1998; 71:104-7. (Pubitemid 28492402)
16. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42:1203-6. (Pubitemid 38332848)
17. Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol 2012; 28:63-9.
18. Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004; 18:337-52.
19. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 2006; 44:2785-91. (Pubitemid 44228572)
20. Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Saf 2000; 22:53-72. (Pubitemid 30058027)
21. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
22. Bauer TM, Lalvani A, Fehrenbach J, et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001; 285:313-9. (Pubitemid 32095034)
23. Larson HE, Borriello SP. Infectious diarrhea due to Clostridium per-fringens. J Infect Dis 1988; 157:390-1.
24. Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 2006; 355:2418-26. (Pubitemid 44903746)
25. Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DW. Clinical manifestation of norovirus gastroenteritis in health care settings. Clin Infect Dis 2004; 39:318-24. (Pubitemid 39050478)
26. Abraham B, Sellin JH. Drug-induced diarrhea. Curr Gastroenterol Rep 2007; 9:365-72.
27. Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant 2008; 42:705-13.
28. Sellin JH. The pathophysiology of diarrhea. Clin Transplant 2001; 15(suppl 4):2-10. (Pubitemid 32509963)
29. Whelan K, Schneider SM. Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol 2011; 27:152-9.
30. Manichanh C, Varela E, Martinez C, et al. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol 2008; 103:1754-61.
31. Kamboj M, Mihu CN, Sepkowitz K, Kernan NA, Papanicolaou GA. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis 2007; 9:265-9. (Pubitemid 350059147)
32. Riddle DJ, Dubberke ER. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13:592-600.
33. Smith SA, Campbell SJ, Webster D, Curley M, Leddin D, Forward KR. A study of the prevalence of cytotoxic and non-cytotoxic Klebsiella oxytoca fecal colonization in two patient populations. Can J Infect Dis Med Microbiol 2009; 20:e169-72. Accessed 1 February 2012.
34. Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbi-otes. Clin Microbiol Rev 2009; 22:349-69.
35. Heimesaat MM, Granzow K, Leidinger H, Liesenfeld O. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens en-terotoxin A in stool samples of patients with antibiotic-associated diarrhea. Infection 2005; 33:340-4. (Pubitemid 41552010)
36. Zollner-Schwetz I, Hogenauer C, Joainig M, et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis 2008; 47: e74-8.
37. Modi N, Wilcox MH. Evidence for antibiotic induced Clostridium per-fringens diarrhoea. J Clin Pathol 2001; 54:748-51. (Pubitemid 32929494)
38. Asha NJ, Wilcox MH. Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhoea. J Med Microbiol 2002; 51:891-4. (Pubitemid 35222792)
39. Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol 2005; 100:1828-34. (Pubitemid 41648440)
40. Flemming K, Ackermann G. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea. Infection 2007; 35:356-8. (Pubitemid 47502352)
41. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:1776-85.
42. Koo HL, Ajami NJ, Jiang ZD, Atmar RL, DuPont HL. Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect 2009; 72:185-7.
43. Festini F, Cocchi P, Mambretti D, et al. Nosocomial rotavirus gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis 2010; 10:235.
44. Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990; 131:711-8. (Pubitemid 20137239)
45. Feuerstadt P, Brandt LJ. Colon ischemia: recent insights and advances. Curr Gastroenterol Rep 2010; 12:383-90.
46. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357:2562-75. (Pubitemid 350294223)
47. Boudjema K, Camus C, Saliba F, et al. Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant 2011; 11:965-76.
48. Lopman BA, Reacher MH, Vipond IB, et al. Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis 2004; 10:1827-34. (Pubitemid 39319375)
49. Savola KL, Baron EJ, Tompkins LS, Passaro DJ. Fecal leukocyte stain has diagnostic value for outpatients but not inpatients. J Clin Micro-biol 2001; 39:266-9. (Pubitemid 32059601)
50. Morrow LE, Gogineni V, Malesker MA. Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Curr Opin Clin Nutr Metab Care 2012; 15:147-50.
51. Liong MT. Safety of probiotics: translocation and infection. Nutr Rev 2008; 66:192-202.